Anthrax Sample Clauses

Anthrax. A disease caused by the spore-forming Bacillus anthracis bacterium, anthrax is another zoonosis from antiquity. Predominantly a disease of herbivores, humans can become infected directly or indirectly from contact with infected animals or animal products (World Health Organization 2008). Anthrax is not considered to be a communicable disease; however, person-to-person transmission (involving the cutaneous form) has been recorded but is extremely rare (Lalitha, Anandi et al. 1988) (Xxxxx and Xxxxxxxx 1998). In animals, anthrax remains endemic and common in some Mediterranean countries, some countries of central and South America and central Asia, some sub-Saharan African countries, and western China. Elsewhere, sporadic cases and outbreaks in people continue to occur (World Health Organization 2008) where there is the disease in animal populations or where humans are exposed to contaminated animal products. Humans are moderately resistant to infection and there is a reasonable evidence that prolonged exposure to widespread low-level environmental contamination (occupationally and non-occupationally) poses a negligible risk (World Health Organization 2008) (Xxxxxxx, Xxxxxxx et al. in preparation) (Xxxxxx, Xxxxxxxx et al. 2007) (Xxxxxx, Xxx Xx et al. 1960) (Wattiau, Govaerts et al. 2009). There is also evidence that even exposure to significant amounts of aerosolised Bacillus anthracis spores results in very few cases of infection (Xxxxxxxx, Gold et al. 1962) (Xxxxxxxx, Xxxxxxxx et al. 1960). There are three main forms of human anthrax: cutaneous, inhalational (the most severe form) and gastrointestinal, the form depending on the route of infection. Only inhalational anthrax is considered within this project and the reader is guided to D2.3 for more detail on the transmission mode for this form.
AutoNDA by SimpleDocs
Anthrax. Mouse anthrax toxin experiments: Reagents (mice, anthrax toxin, experimental materials) 50,000 In Vitro experiments at Xxxxxxx laboratory: Salary support (1 technician) 75,000 Salary support (part time technical assistance) 5,000 Principal Investigator (Xx. Xxxxxxx)- 20% time 30,000 Materials for in vitro experiments: -Cells: mouse Raw 264.7 cells, human U937 cells, 10,000 Human peripheral blood mononuclear cells (PBMC), human fibroblasts -ELISA and Electrochemiluminescence assays for interleukin (IL)-1, IL-6, 25,000 XX-0, XX-00, XX-00, Xxxxx necrosis factor (TNF), IL-1 receptor antagonist. -Miscellaneous materials (plasticware, tissue culture medium components) 10,000 Equipment: -ELISA plate washer 6,000
Anthrax. US Dollars In Vitro experiments at Xxxxxxx laboratory: Salary support (1 technician) 75,000 Salary support (part time technical assistance) 35,000 Principal Investigator (Xx. Xxxxxxx) - 20% time 30,000 Materials: -ELISA and Electrochemiluminescence assays for interleukin (IL)-1, IL-6, 30,000 XX-0, XX-00, XX-00, Xxxxx necrosis factor (TNF), IL-1 receptor antagonist. -Miscellaneous materials (plasticware, tissue culture medium components) 20,000 -Alpha-l-antitrypsin (clinical grade) 10,000 Equipment: -PCR Machine 10,000

Related to Anthrax

  • Baxter and Nexell shall cooperate in any action taken by a third party solely involving a nullity action, opposition, reexamination or any other action taken by such third party alleging the invalidity or unenforceability of any Licensed Intellectual Property. Both parties agree to share equally in the cost of the defense of such Licensed Intellectual Property.

  • Xxxxxxxx Tobacco Co the jury returned a verdict in favor of the plaintiff, found RJR Tobacco to be 45% at fault, the decedent, Xxxxxxxx Xxxxx, to be 40% at fault, and the remaining defendant to be 15% at fault, and awarded $6 million in compensatory damages and $17 million in punitive damages against each defendant.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • XXXXXAS xx xxcordance xxxx Xxxx 00x-1(k) xxder the Securities Exchange Act of 1934 (the "Act"), only one statement containing the information required by Schedule 13G and any amendments thereto need be filed whenever two or more persons are required to file such a statement or any amendments thereto with respect to the same securities, provided that said persons agree in writing that such statement or any amendment thereto is filed on behalf of them.

  • Commercial Milestone Payments For each Licensed Product, Licensee shall pay Arvinas the following one-time milestone event payments when the aggregate Net Sales of such Licensed Product in one or more particular country(ies) for a given calendar year (“Annual Net Sales”), where such Licensed Product is a Valid Claim Licensed Product at the time of sale in each of such country(ies), first achieves the corresponding threshold as set forth in this Section 6.3.2 below, subject to the terms of this Section 6.3 and the payment provisions in Article 7 below: Commercial Milestone Event Milestone Event Payment (US$)

  • Xxxxx Name: Xxxxxxx X. Xxxxx Title: Assistant Treasurer

  • XXXXXXX COMPANY By: ____________________________________ Name: Title: The undersigned hereby acknowledges receipt of an executed original of this Agreement, together with a copy of the prospectus for the Plan, dated ________, summarizing key provisions of the Plan, and accepts the award of the Deferred Stock Units granted hereunder on the terms and conditions set forth herein and in the Plan. Date: ______________________ Grantee:

  • Product Quality 4.1 The following provisions shall apply to Product after Production:

Time is Money Join Law Insider Premium to draft better contracts faster.